SIMILAR PATTERNS OF AMINO ACIDS FOR 6EXI_B_ADNB502
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1n11 | ANKYRIN (Homo sapiens) |
PF00023(Ank)PF12796(Ank_2)PF13637(Ank_4)PF13857(Ank_5) | 5 | HIS A 673GLN A 644ASN A 665LEU A 669HIS A 640 | None | 1.40A | 6exiB-1n11A:undetectable | 6exiB-1n11A:11.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | HIS A 54THR A 56LYS A 230ASP A 234ASN A 391LEU A 392HIS A 398MET A 403PHE A 407 | ADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)NAD A 501 (-3.0A)ADN A 502 ( 4.9A)ADN A 502 ( 3.5A)ADN A 502 (-3.6A)None | 0.71A | 6exiB-1v8bA:55.2 | 6exiB-1v8bA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gj4 | GLYCOGENPHOSPHORYLASE,MUSCLE FORM (Oryctolaguscuniculus) |
PF00343(Phosphorylase) | 5 | THR A 671THR A 668ASN A 284LEU A 380HIS A 571 | None | 1.16A | 6exiB-2gj4A:2.3 | 6exiB-2gj4A:7.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 69THR A 71GLN A 73THR A 74HIS A 363LEU A 410PHE A 425 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.6A)ADN A 500 (-4.5A)ADN A 500 ( 3.7A)ADN A 500 ( 4.8A)ADN A 500 (-4.8A) | 1.03A | 6exiB-3ce6A:55.7 | 6exiB-3ce6A:60.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 69THR A 71GLN A 73THR A 74LYS A 248ASP A 252ASN A 409LEU A 410HIS A 416MET A 421PHE A 425 | ADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.6A)ADN A 500 (-4.5A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)NAD A 550 (-3.0A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.66A | 6exiB-3ce6A:55.7 | 6exiB-3ce6A:60.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | HIS A 52THR A 54GLN A 56THR A 57ASN A 345LEU A 346HIS A 352MET A 357PHE A 361 | ADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-3.8A)ADN A 438 (-4.6A)NAD A 439 (-3.1A)ADN A 438 ( 4.8A)ADN A 438 ( 3.6A)ADN A 438 (-3.7A)None | 0.18A | 6exiB-3g1uA:53.6 | 6exiB-3g1uA:71.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 52THR A 54GLN A 56THR A 57HIS A 300LEU A 346PHE A 361 | ADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-3.8A)ADN A 438 (-4.6A)ADN A 438 ( 4.0A)ADN A 438 ( 4.8A)None | 1.05A | 6exiB-3g1uA:53.6 | 6exiB-3g1uA:71.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62THR A 64GLN A 66THR A 67HIS A 344LEU A 388PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A)None | 1.03A | 6exiB-3glqA:59.0 | 6exiB-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 62THR A 64GLN A 66THR A 67LYS A 229ASP A 233ASN A 387LEU A 388HIS A 394MET A 399PHE A 403 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 (-3.0A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.64A | 6exiB-3glqA:59.0 | 6exiB-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3gvp | ADENOSYLHOMOCYSTEINASE 3 (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 234THR A 236GLN A 238THR A 239LYS A 365 | None | 0.63A | 6exiB-3gvpA:42.6 | 6exiB-3gvpA:51.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 52THR A 54GLN A 56THR A 57HIS A 300LEU A 346PHE A 361 | ADN A 439 ( 4.7A)ADN A 439 (-2.7A)ADN A 439 (-3.6A)ADN A 439 (-4.7A)NoneADN A 439 ( 4.7A)None | 1.05A | 6exiB-3h9uA:55.1 | 6exiB-3h9uA:13.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 52THR A 54GLN A 56THR A 57LYS A 185ASP A 189ASN A 345LEU A 346HIS A 352MET A 357PHE A 361 | ADN A 439 ( 4.7A)ADN A 439 (-2.7A)ADN A 439 (-3.6A)ADN A 439 (-4.7A)NAD A 438 ( 3.9A)NAD A 438 ( 4.4A)NAD A 438 (-2.9A)ADN A 439 ( 4.7A)ADN A 439 ( 3.3A)ADN A 439 ( 3.7A)None | 0.70A | 6exiB-3h9uA:55.1 | 6exiB-3h9uA:13.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hv0 | TRYPTOPHANYL-TRNASYNTHETASE (Cryptosporidiumparvum) |
PF00579(tRNA-synt_1b) | 5 | THR A 305GLN A 245THR A 243LEU A 302HIS A 248 | None | 1.44A | 6exiB-3hv0A:2.6 | 6exiB-3hv0A:11.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 55THR A 57GLN A 59THR A 60HIS A 337LEU A 381PHE A 396 | ADN A 500 (-4.0A)ADN A 500 (-2.8A) K A 2 ( 3.3A)ADN A 500 (-4.6A)ADN A 500 ( 3.6A)ADN A 500 ( 4.8A)None | 1.04A | 6exiB-3n58A:60.1 | 6exiB-3n58A:14.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 55THR A 57GLN A 59THR A 60LYS A 222ASP A 226ASN A 380LEU A 381HIS A 387MET A 392PHE A 396 | ADN A 500 (-4.0A)ADN A 500 (-2.8A) K A 2 ( 3.3A)ADN A 500 (-4.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)NAD A 550 (-3.0A)ADN A 500 ( 4.8A)ADN A 500 (-3.4A)ADN A 500 (-3.7A)None | 0.65A | 6exiB-3n58A:60.1 | 6exiB-3n58A:14.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62THR A 64GLN A 66THR A 67HIS A 350LEU A 398PHE A 413 | ADE A 506 (-4.6A)ADE A 506 (-2.8A)ADE A 506 (-3.8A)ADE A 506 (-4.5A)NoneADE A 506 ( 4.7A)ADE A 506 (-4.9A) | 1.07A | 6exiB-3oneA:55.4 | 6exiB-3oneA:64.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 62THR A 64GLN A 66THR A 67LYS A 235ASP A 239ASN A 397LEU A 398HIS A 404MET A 409PHE A 413 | ADE A 506 (-4.6A)ADE A 506 (-2.8A)ADE A 506 (-3.8A)ADE A 506 (-4.5A)NAD A 501 ( 4.2A)NAD A 501 ( 4.5A)NAD A 501 (-3.0A)ADE A 506 ( 4.7A)ADE A 506 (-3.4A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.67A | 6exiB-3oneA:55.4 | 6exiB-3oneA:64.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 58THR A 60GLN A 62THR A 63HIS A 342LEU A 386PHE A 401 | ADN A 501 (-4.0A)ADN A 501 (-2.8A)NH4 A 502 ( 3.1A)ADN A 501 (-4.5A)ADN A 501 ( 3.7A)ADN A 501 ( 4.7A)ADN A 501 (-4.8A) | 1.05A | 6exiB-4lvcA:63.5 | 6exiB-4lvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 58THR A 60GLN A 62THR A 63LYS A 227ASP A 231ASN A 385LEU A 386HIS A 392MET A 397PHE A 401 | ADN A 501 (-4.0A)ADN A 501 (-2.8A)NH4 A 502 ( 3.1A)ADN A 501 (-4.5A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)NAD A 503 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.5A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.64A | 6exiB-4lvcA:63.5 | 6exiB-4lvcA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uq6 | TARTRATE-RESISTANTACID PHOSPHATASETYPE 5 (Sus scrofa) |
PF00149(Metallophos) | 5 | HIS A 195THR A 198ASP A 14ASN A 91HIS A 186 | PO4 A 404 (-3.8A)None FE A 402 ( 3.1A)PO4 A 404 ( 2.6A) FE A 403 ( 3.4A) | 1.30A | 6exiB-5uq6A:undetectable | 6exiB-5uq6A:15.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uq6 | TARTRATE-RESISTANTACID PHOSPHATASETYPE 5 (Sus scrofa) |
PF00149(Metallophos) | 5 | HIS A 195THR A 198HIS A 223ASN A 91HIS A 186 | PO4 A 404 (-3.8A)None FE A 402 (-3.4A)PO4 A 404 ( 2.6A) FE A 403 ( 3.4A) | 1.34A | 6exiB-5uq6A:undetectable | 6exiB-5uq6A:15.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | HIS A 53THR A 55THR A 58LYS A 241ASP A 245ASN A 403LEU A 404HIS A 410MET A 415PHE A 419 | SAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-4.2A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)NAD A 501 (-2.9A)SAH A 502 ( 4.7A)SAH A 502 ( 3.5A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.73A | 6exiB-5utuA:52.7 | 6exiB-5utuA:9.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | HIS A 59THR A 61THR A 64LYS A 227ASP A 231ASN A 388LEU A 389HIS A 395MET A 400PHE A 404 | ADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-4.4A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)NAD A 501 (-3.1A)ADN A 502 ( 4.7A)ADN A 502 ( 3.4A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.69A | 6exiB-5v96A:56.7 | 6exiB-5v96A:13.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 55THR A 57THR A 60LYS A 186ASP A 190MET A 358PHE A 362 | 9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNAD A 501 (-4.1A)9W4 A 502 (-3.6A)None | 1.16A | 6exiB-5w4bA:47.5 | 6exiB-5w4bA:12.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186ASP A 190ASN A 346LEU A 344HIS A 353 | NoneNAD A 501 (-4.1A)NAD A 501 (-3.1A)NAD A 501 (-4.0A)NAD A 501 (-4.5A) | 1.35A | 6exiB-5w4bA:47.5 | 6exiB-5w4bA:12.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LYS A 186ASP A 190ASN A 346LEU A 347HIS A 353MET A 358 | NoneNAD A 501 (-4.1A)NAD A 501 (-3.1A)9W4 A 502 (-4.1A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A) | 1.12A | 6exiB-5w4bA:47.5 | 6exiB-5w4bA:12.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | THR A 60LYS A 186ASP A 190HIS A 353MET A 358PHE A 362 | NoneNoneNAD A 501 (-4.1A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 1.32A | 6exiB-5w4bA:47.5 | 6exiB-5w4bA:12.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 58THR A 60GLN A 62THR A 63HIS A 306LEU A 352PHE A 367 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.8A)ADN A 501 (-4.5A)ADN A 501 ( 3.7A)ADN A 501 ( 4.8A)None | 1.04A | 6exiB-6aphA:29.7 | 6exiB-6aphA:69.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 11 | HIS A 58THR A 60GLN A 62THR A 63LYS A 191ASP A 195ASN A 351LEU A 352HIS A 358MET A 363PHE A 367 | ADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.8A)ADN A 501 (-4.5A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)NAD A 500 (-3.1A)ADN A 501 ( 4.8A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A)None | 0.65A | 6exiB-6aphA:29.7 | 6exiB-6aphA:69.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 7 | HIS B 61THR B 63GLN B 65THR B 66HIS B 323LEU B 376PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) K B 504 ( 3.0A)ADN B 502 (-4.6A) ZN B 505 (-3.2A)ADN B 502 ( 4.8A)ADN B 502 (-4.9A) | 1.01A | 6exiB-6f3mB:51.2 | 6exiB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 11 | HIS B 61THR B 63GLN B 65THR B 66LYS B 194ASP B 198ASN B 375LEU B 376HIS B 382MET B 387PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) K B 504 ( 3.0A)ADN B 502 (-4.6A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)NAD B 501 (-3.0A)ADN B 502 ( 4.8A)ADN B 502 (-3.4A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.68A | 6exiB-6f3mB:51.2 | 6exiB-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 7 | HIS A 56THR A 58GLN A 60THR A 61HIS A 304LEU A 350PHE A 365 | ADN A 501 (-3.9A)ADN A 501 (-2.8A) NA A 503 ( 3.2A)ADN A 501 (-4.6A)ADN A 501 ( 3.6A)ADN A 501 ( 4.7A)None | 1.03A | 6exiB-6gbnA:31.6 | 6exiB-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 11 | HIS A 56THR A 58GLN A 60THR A 61LYS A 189ASP A 193ASN A 349LEU A 350HIS A 356MET A 361PHE A 365 | ADN A 501 (-3.9A)ADN A 501 (-2.8A) NA A 503 ( 3.2A)ADN A 501 (-4.6A)ADN A 501 (-2.9A)ADN A 501 (-2.7A)NAD A 502 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.4A)ADN A 501 (-3.6A)None | 0.65A | 6exiB-6gbnA:31.6 | 6exiB-6gbnA:undetectable |